近日,管理部门批准了Ventana® CLDN18 (43-14A) RxDx检测,这一创新的免疫组织化学(IHC)伴随诊断技术旨在识别胃或胃食管交界处(GEJ)腺癌患者中的Claudin 18.2 (CLDN18.2)蛋白表达。该检测方法对于筛选适合接受zolbetuximab-clzb (Vyloy)治疗的患者具有重要意义。紧接着,在2024年10月22日,FDA还批准了zolbetuxim...
VENTANA anti-ALK (D5F3) Rabbit Monoclonal Primary Antibody is intended for laboratory use in the qualitative detection of the anaplastic lymphoma kinase (ALK) protein in formalin-fixed, paraffin-embedded non-small cell lung carcinoma (NSCLC) tissue stain
IVD Identifying ALK+ NSCLC patients for targeted treatment The VENTANA ALK (D5F3) CDx Assay empowers your lab to provide timely results with a four-and-one-half hour run time using fully automated, ready-to-use reagents. About the VENTANA ALK (D5F3) CDx Assay ...